Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005143 |
---|---|
Receipt number | R000006066 |
Scientific Title | A Phase 2 study of Carboplatin plus Pemetrexed plus Bevacizumab as first-line therapy for stage3B/4 non-squamous non-small-cell lung cancer |
Date of disclosure of the study information | 2011/02/26 |
Last modified on | 2014/09/02 13:49:26 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/02/25 14:44:46 | ||
2 | Update | 2014/09/02 13:49:26 | Email Post marketing survey by drug manufacture etc., specified by Japanese law. |